Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

100%

5 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
4(80.0%)
Phase 4
1(20.0%)
5Total
Phase 3(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01246427Phase 3Completed

Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer

Role: collaborator

NCT01066741Phase 3Terminated

Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer

Role: collaborator

NCT00914329Phase 3Completed

Gelsemium Sempervirens in Anticipatory Anxiety

Role: collaborator

NCT00409071Phase 3Completed

Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.

Role: collaborator

NCT00774293Phase 4Completed

Homoeopathic Association in Aortic Valve Surgery

Role: lead

All 5 trials loaded